Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plant glycoprotein 1,2-alpha-mannosidase I is a crucial enzyme in the N-glycan processing pathway, primarily located in the endoplasmic reticulum and Golgi apparatus (Liebminger et al., 2009, Plant Cell). It catalyzes the sequential removal of alpha-1,2-linked mannose residues from the precursor Man9GlcNAc2 to form Man5GlcNAc2, a critical step for the synthesis of complex N-glycans (Strasser, 2016, Front. Plant Sci.). In plants like Arabidopsis thaliana, this enzyme family (including MNS1, MNS2, and MNS3) is essential for proper root development and cell wall biosynthesis (Liebminger et al., 2009, Plant Cell). From a therapeutic perspective, plant mannosidase I is a primary target for glycan engineering in molecular farming, where plants are used to produce recombinant human proteins (Strasser, 2022, Front. Plant Sci.). By inhibiting or knocking out this enzyme, researchers can prevent the addition of plant-specific immunogenic sugars, such as beta-1,2-xylose and alpha-1,3-fucose, ensuring the production of safer biopharmaceuticals (Strasser, 2016, Front. Plant Sci.). Potent inhibitors like kifunensine are widely used to block its activity, facilitating the production of high-mannose glycoforms used in treating lysosomal storage diseases like Gaucher disease (Elbein et al., 1990, J. Biol. Chem.). Kifunensine is specifically employed in the manufacture of Velaglucerase alpha to improve mannose-receptor mediated uptake into macrophages (Wikipedia, 2024). Understanding and modulating this enzyme is therefore vital for both plant physiology and the advancement of plant-based biomanufacturing (Strasser, 2022, Front. Plant Sci.).
Competitive inhibition of alpha-1,2-mannosidase activity, preventing the removal of terminal alpha-1,2-linked mannose residues from precursor N-glycans (Elbein et al., 1990, J. Biol. Chem.).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein 1,2-alpha-mannosidase I (MNS1).